Recent studies demonstrated that quercetin could inhibit the interaction of PD-1/PD-L1 to relieve immunosuppression in the TME [124] and remodel the TME by reducing the α-SMA+ fibroblast populations at tumor sites [111]. The gene discussed is CD274; the disease is neoplasm.